Skip to content

Leave the editing and optimization to us so you can focus your research.

Advancing your immunological research just got seamless.

T-cell-general-purple

Whether you're working with CD4+ or CD8+ T-cells, our next-generation Knockout T-cell Pools are paving the way for safer, more effective, and agile healthcare studies.

Fast-track your findings without compromising functionality.

Using gene editing to advance your research should be an intuitive part of your workflow—not a difficult process that requires months of planning and endless resources. Consider our tools your bridge between theory and therapeutic breakthroughs. Avoid sinking time and resources into optimization and spend more time realizing impactful research outcomes. 

With this new tool fueling your lab’s research, you can leverage: 

  • Guaranteed editing efficiency: Our unique multi-guide technology provides optimized guide design, so you can expect more than 80 percent editing efficiency. 
  • Functional cells for reliable assays: With proven post-editing performance, our T-cells provide the confidence you need to drive your discoveries forward. 
  • Save precious time and resources: Don’t risk slowdowns or valuable samples when you can get two vials of more than 1 million cells in less than three weeks.

Limited Time Offer- 15% off on all KO Human T-cell Pools!

EditCo's next-generation Knockout Human T-cell Pools are here to help you take your research to the next level. Until September 22nd, 2024, save 15% on all KO Human T-cell Pools, including edited-to-order CD4+ and CD8+ T-cells. Experience unmatched editing efficiency and functionality, making your studies faster, safer, and more effective. Don’t miss out—boost your research today!

Download the Poster:

Rapid and Efficient Genome Editing for Human Primary T-Cells

With proven post-editing performance, viability, and functionality, our T-cells are ready to give you the confidence you need to drive your discoveries forward. Read more and view data with our CD4+ T-cell and CD8+ T-cell flyers. 

Want details quickly? We'll keep this simple. Accelerate your research now.